Macquarie Group’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-405,952
Closed -$14.5M 1651
2014
Q4
$14.5M Buy
405,952
+102,406
+34% +$3.06M 0.03% 441
2014
Q3
$7.89M Buy
303,546
+78,868
+35% +$2.27M 0.02% 568
2014
Q2
$7.43M Sell
224,678
-308
-0.1% -$8.9K 0.02% 595
2014
Q1
$6.73M Buy
224,986
+116,123
+107% +$4M 0.01% 596
2013
Q4
$3.31M Sell
108,863
-20,918
-16% -$576K 0.01% 762
2013
Q3
$4.13M Sell
129,781
-8,309
-6% -$191K 0.01% 662
2013
Q2
$2.08M Buy
+138,090
New +$1.91M ﹤0.01% 891

Other funds holding NPSP

Macquarie Group's NPSP Position: Q1 2015 in Review

Macquarie Group sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 405,952 shares — an estimated $14.5M sold.

Macquarie Group first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $14.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Macquarie Group reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Macquarie Group sold 405,952 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $14.5M.
  • Macquarie Group first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Macquarie Group's NPS PHARMACEUTICALS INC position peaked at $14.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Macquarie Group's 13F filing for Q1 2015, filed 18 May 2015.